Ani Pharmaceuticals Inc (ANIP)

Oct 01, 2026

Form 4 ANI Pharmaceuticals Inc For: 1 October By Investing.com - Investing.com Australia

Oct 01, 2026

Oct 01, 2026

Ani Pharmaceuticals SVP & CFO Stephen Carey sells $208,050 in stock - Investing.com Nigeria

Oct 01, 2026

Sep 30, 2026

ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada

Sep 30, 2026

Sep 30, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Stock: Insider Stephen Carey Sells 2,850 Shares - MarketBeat

Sep 30, 2026

Sep 30, 2026

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 30, 2026

Sep 30, 2026

After selling 2,850 shares, ANI Pharmaceuticals (ANIP) CFO holds 168,993 shares. - Stock Titan

Sep 30, 2026

Sep 30, 2026

ANI Pharmaceuticals Announces New Fluocinolone Acetonide - GlobeNewswire

Sep 30, 2026

Sep 28, 2026

Implied Volatility Surging for ANI Pharmaceuticals Stock Options - TradingView

Sep 28, 2026

Sep 26, 2026

183,066 Shares of ANI Pharmaceuticals, Inc. $ANIP Acquired by Bank of America Corp DE - MarketBeat

Sep 26, 2026

Sep 24, 2026

ANIP5868601 Bond Profile: Coupon and Redemption - TradingView

Sep 24, 2026

Sep 24, 2026

ANI Pharmaceuticals: Cortrophin’s Q4 Test, With Generics Funding The Build (NASDAQ:ANIP) - Seeking Alpha

Sep 24, 2026

Sep 24, 2026

ANI Pharmaceuticals, Inc. (ANIP) Stock forecasts - Yahoo Finance Singapore

Sep 24, 2026

Sep 23, 2026

Ocular Therapeutix and ANI Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance

Sep 23, 2026

Sep 23, 2026

ANI Pharmaceuticals, Inc. (ANIP) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026

Sep 23, 2026

ANI Pharmaceuticals Initiated at Perform by Oppenheimer - Moomoo

Sep 23, 2026

Sep 23, 2026

Oppenheimer initiates ANI Pharmaceuticals stock with Perform rating By Investing.com - Investing.com Nigeria

Sep 23, 2026

Sep 23, 2026

ANI Pharmaceuticals gets FDA approval for generic everolimus By Investing.com - Investing.com South Africa

Sep 23, 2026

Sep 23, 2026

ANI Pharmaceuticals gets FDA approval for generic everolimus - Investing.com

Sep 23, 2026

Sep 23, 2026

Oppenheimer initiates ANI Pharmaceuticals stock with Perform rating - Investing.com

Sep 23, 2026

Sep 23, 2026

ANI Pharmaceuticals Receives FDA Approval for Generic Everolimus Tablets for Oral Suspension - Quiver Quantitative

Sep 23, 2026

Sep 23, 2026

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension - GlobeNewswire

Sep 23, 2026

Sep 23, 2026

Oppenheimer Initiates ANI Pharmaceuticals at Perform With $85 Price Target - Yahoo Finance

Sep 23, 2026

Sep 21, 2026

ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth - Eastern Progress

Sep 21, 2026

Sep 16, 2026

ANI Pharmaceuticals (ANIP) President & CEO Nikhil Lalwani Sells 5,400 Shares - GuruFocus

Sep 16, 2026

Sep 16, 2026

Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $383,400.00 in Stock - MarketBeat

Sep 16, 2026

Sep 16, 2026

ANI Pharmaceuticals (ANIP) CEO sells 5,400 shares in pre-set trading plan - Stock Titan

Sep 16, 2026

Sep 16, 2026

Ani Pharmaceuticals director Thoma sells $71,530 in shares By Investing.com - Investing.com South Africa

Sep 16, 2026

Sep 15, 2026

ANI Pharmaceuticals (NASDAQ: ANIP) insider lines up $380,000 stock sale for 2026 - Stock Titan

Sep 15, 2026

Sep 15, 2026

ANI Pharmaceuticals Executive Cook Meredith Sells 500 Shares at $70.79 Each (NASDAQ: ANIP) - Kalkine Media

Sep 15, 2026

Sep 15, 2026

Squarepoint Ops LLC Sells 37,088 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 15, 2026

Sep 15, 2026

Ani Pharmaceuticals’ Meredith Cook sells $35,395 in common stock By Investing.com - Investing.com Canada

Sep 15, 2026

Sep 14, 2026

Ani Pharmaceuticals’ Meredith Cook sells $35,395 in common stock - Investing.com

Sep 14, 2026

Sep 14, 2026

ANI Pharmaceuticals (ANIP) Insider Sale: SVP, General Counsel & Secretary Meredith Cook Sells 500 Shares - GuruFocus

Sep 14, 2026

Sep 14, 2026

Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) VP Sells $35,395.00 in Stock - MarketBeat

Sep 14, 2026

Sep 14, 2026

Amundi Boosts Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 14, 2026

Sep 13, 2026

VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 13, 2026

Sep 13, 2026

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Sep 13, 2026

Sep 11, 2026

ANI Pharmaceuticals (NASDAQ: ANIP) director plans $71K share sale - Stock Titan

Sep 11, 2026

Sep 11, 2026

WINTON GROUP Ltd Takes $4.56 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 11, 2026

Sep 10, 2026

ANI Pharmaceuticals at Wells Fargo conference: rare disease push gains pace - Investing.com

Sep 10, 2026

Sep 10, 2026

ANIP: Record growth in rare disease and generics, with strong financials and strategic expansion - TradingView

Sep 10, 2026

Sep 09, 2026

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD By Investing.com - Investing.com Nigeria

Sep 09, 2026

Sep 09, 2026

ETFs Investing in ANI Pharmaceuticals, Inc. Stocks - TradingView

Sep 09, 2026

Sep 09, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week LowTime to Sell? - MarketBeat

Sep 09, 2026

Sep 09, 2026

ANI Pharmaceuticals stock hits 52-week low at 70.03 USD - investing.com

Sep 09, 2026

Sep 09, 2026

ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat

Sep 09, 2026

Sep 05, 2026

Legal & General Group Plc Buys Shares of 45,075 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 05, 2026